 Cyclic adenosine responses hormone prostaglandin isoproterenol dermal fibroblasts patients familial benign hypercalcemia Plasma concentrations PTH much calcium phosphorus level patients familial benign hypercalcemia FBH familial hypocalciuric hypercalcemia primary hyperparathyroidism data tissue hypersensitivity PTH FBH hypothesis dermal fibroblasts abdominal skin biopsies patients FBH age- sex-matched controls surrogate PTH-responsive tissues Cells plastic plates vehicle human PTH- prostaglandin isoproterenol min presence isobutylmethylxanthine cellular cAMP RIA All cells dose-dependent increases cAMP isoproterenol consistent significant differences control FBH fibroblasts maximal responses agonists half-maximal stimulation PTH normal FBH cells data consistent increased tissue sensitivity PTH FBH